Notably, we observed two patients with pathogenic and likely pathogenic variants in GSK and ABCC8 (Supplementary Table S3), respectively, in which mutations lead to familial hyperinsulinemic hypoglycemia. Here, ABCC8 is linked to hyperinsulinemic hypoglycemia.